Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GMP Quality Management Systems For FDA Will Be Proposed By December

Executive Summary

FDA expects to release a draft on improving the agency's good manufacturing practices management systems by Dec. 1

You may also be interested in...



Rx Manufacturing Survey Will Provide Benchmark Performance “Scorecards”

FDA is encouraging drug makers to participate in a benchmarking study of organizational and management practices in manufacturing

Rx Manufacturing Survey Will Provide Benchmark Performance “Scorecards”

FDA is encouraging drug makers to participate in a benchmarking study of organizational and management practices in manufacturing

“Honest And Straightforward” 483 Responses May Avert Warning Letters

CDER is weighing companies' responses to FDA-483 inspection reports in considering whether to issue warning letters, Center for Drug Evaluation & Research Office of Compliance Director David Horowitz said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042425

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel